To offer this technically advanced surgery demonstrates CPMC leadership in providing patients with the most minimally invasive surgical options.
San Francisco, CA (PRWEB) December 01, 2013
A surgical team at California Pacific Medical Center, San Francisco, performed their first da Vinci® Single-Site™ surgery on 11/18/13. The patient’s large ovarian cyst was removed through one tiny incision in the belly button, making the procedure virtually scarless.
Led by Leslie Kardos M.D., Director Robotic Surgery, Division Gynecology, CPMC, the team removed the Ovarian Cyst using Single-Site™ instruments on a da Vinci® Surgical System. The minimally invasive procedure is traditionally called a laparoscopic or open ovarian cystectomy. Using robotic assistance, surgeons removed the 9 cm cyst through an incision of approximately one inch.
The Food and Drug Administration cleared the specialized Single-Site instruments for use with the da Vinci Surgical System in December 2011.
"Neither robotic-assisted surgery nor single-incision surgery is new, but combining the two to remove diseased female organs requires additional training and special equipment," says Dr. Kardos. "To offer this technically advanced surgery demonstrates CPMC leadership in providing patients with the most minimally invasive surgical options."
Dr Kardos is one of a group of surgeons in the country who has received training to perform the surgery.
“Single-Site instruments used with the da Vinci Surgical System are the next step in the evolution of surgical technologies,” Dr Kardos said. “We are truly excited to be a leader today in the surgical treatment of tomorrow.”
Potential benefits of Single-Site surgery may include virtually scarless surgery, minimal pain, low blood loss, fast recovery, a short hospital stay and high patient satisfaction.
During the procedure, the surgeon sits comfortably at a console, viewing a 3D, high-definition image of the patient’s anatomy. The surgeon uses controls below the viewer to move the instrument arms and camera. In real-time, the system translates the surgeon's hand, wrist and finger movements into more precise movements of the miniaturized instruments inside the patient.
Unlike traditional robotic surgeries requiring three to five small incisions, this technology allows for a single incision in the belly button where instruments are placed and where the diseased organ is removed.
Most people who require removal of a benign ovarian cyst, an ovary, or need a hysterectomy or a are candidates for the robotic-assisted, single-incision surgery. According to the American Academy of Gynecologic Laparoscopists, surgery is the recommended treatment for many benign gynecologic growths and minimally invasive surgery should be offered whenever possible.
More than 600,000 women in the U.S. have their uterus removed each year. Most are performed with traditional large incisions. Now women may be candidaes for laparoscopic, robotic or single incision robotic surgery.
Potential risks include conversion to other surgical techniques and multiple incisions. All surgery presents risk, including da Vinci Surgery. Serious complications may occur in any surgery, up to and including death.
Other risks include injury to tissues and organs. Risks specific to gynecologic surgery, including surgery with da Vinci, include damage to bowel or bladder,urinary retention and hernia (bulging tissue) at the incision site.
CPMC offers various types of robotic-assisted surgeries at its Pacific Campus. In addition to hysterectomy, myomectomy,endometriosis excision and ovarian cyst removal, CPMC surgeons perform robotic-assisted surgery in urology, general surgery and cardiothoracic surgery. CPMC also offers a wide range of minimally invasive conventional laparoscopic surgeries.
For information on robotic and other minimally invasive surgeries contact us or visit our web site at http://www.pacificgynsurgicalgroup.com.
Contact:
Leslie Kardos MD
2100 Webster St #319
San Francisco, Ca, 94115
415 923-3130
info(at)pacificgynsurgicalgroup(dot)com
